Latest / The Well-Built Life / The Liver's Metabolic Role in Systemic Health
Transcript
- 0:00Speaker 1: Hey, everyone, welcome back to the Well Built Life. I
- 0:04Speaker 1: am Rachel Caldwell alongside Thomas Bennett, and we are so
- 0:07Speaker 1: glad you are tuning in. We are here to cut
- 0:10Speaker 1: through the noise, skip the intense jargon and extreme rules,
- 0:14Speaker 1: and share simple, practical habits that help you feel stronger, healthier,
- 0:19Speaker 1: and more balanced every single day. Grab a drink, get comfortable,
- 0:23Speaker 1: and let's dive in. All right, Thomas, let's dive into this.
- 0:28Speaker 1: The liver is often seen as the metabolic headquarters of
- 0:31Speaker 1: the body. But what exactly does that mean?
- 0:34Speaker 2: Exactly, Rachel, the liver is like the central processing unit
- 0:38Speaker 2: for all metabolic tasks. It handles everything from breaking down
- 0:42Speaker 2: food into usable energy to filtering out toxins. Let's break
- 0:46Speaker 2: it down step by step on why it's so crucial.
- 0:48Speaker 1: Great. First off, the liver plays a pivotal role in
- 0:52Speaker 1: glucose regulation. It's like the body's own little factory that
- 0:56Speaker 1: can manage glucose levels so precisely. That but even when
- 1:00Speaker 1: you are eating a massive meal, your blood sugar doesn't spike.
- 1:04Speaker 1: How does it do that?
- 1:05Speaker 2: That's a great question. The liver can store and release
- 1:08Speaker 2: glucose as needed when you are fasting it releases stored
- 1:12Speaker 2: glucose to keep your blood sugar level stable post meal.
- 1:16Speaker 2: It can take in excess glucose, convert it to glycogen,
- 1:19Speaker 2: and store it for later. This glucose regulation is automatic
- 1:23Speaker 2: and finely tuned, which is why early metabolic dysfunction can
- 1:27Speaker 2: be hard to spot.
- 1:28Speaker 1: That's fascinating. So if the liver is so good at
- 1:32Speaker 1: managing glucose, what does it mean when we start to
- 1:35Speaker 1: see issues like staytosis and fibrosis.
- 1:38Speaker 2: Statosis or fatty liver disease is often the first sign
- 1:42Speaker 2: of trouble. It's what happens when the liver starts to
- 1:45Speaker 2: accumulate too much fat. And it's not just about alcohol anymore.
- 1:49Speaker 2: It can happen due to a chronic calorie surplus, where
- 1:52Speaker 2: the liver converts excess energy from any source like fructose
- 1:56Speaker 2: or alcohol into triglycerides and then packages them into particles
- 2:00Speaker 2: for storage elsewhere.
- 2:01Speaker 1: Right, And as this fat accumulates, it starts to interfere
- 2:05Speaker 1: with the liver's functions. Right.
- 2:08Speaker 2: What happens then, Yes, exactly, as the fat builds up,
- 2:12Speaker 2: it begins to cause inflammation. This is where steutohippotitis comes
- 2:17Speaker 2: in the liver cells start to die and immune cells
- 2:20Speaker 2: get involved, causing more inflammation. This cycle can lead to
- 2:25Speaker 2: irreversible fibrosis, where the liver starts to lose its ability
- 2:29Speaker 2: to regenerate and function properly, eventually leading to cirrhosis.
- 2:34Speaker 1: And the damage doesn't stop there. What about the cancer risk?
- 2:38Speaker 1: How does the liver's architecture play a role in that the.
- 2:41Speaker 2: Liver's fibrosis or scarring significantly increases the risk of cancer.
- 2:47Speaker 2: Studies show that with chronic inflammation and scarring, the liver
- 2:51Speaker 2: becomes even more prone to genetic mutations and the development
- 2:54Speaker 2: of cancer. The more scarring, the greater the risk. This
- 2:58Speaker 2: is why it's crucial to catch and treat these issues early.
- 3:02Speaker 1: That's a lot to take in. And let's not forget
- 3:04Speaker 1: about alcohol. How does it specifically affect the liver and
- 3:08Speaker 1: contribute to these issues.
- 3:09Speaker 2: Alcohol is a double edged sword. On one hand, it
- 3:13Speaker 2: can cause fatty liver independently of caloric intake. On the other,
- 3:17Speaker 2: when combined with a caloric surplus, it creates a perfect storm. Acetaldehyde,
- 3:23Speaker 2: the toxic byproduct of alcohol metabolism, accumulates faster when consumed
- 3:28Speaker 2: in large quantities, leading to faster liver damage. It's a
- 3:32Speaker 2: complex interplay between genetics, lifestyle, and environment that can really
- 3:37Speaker 2: impact liver health.
- 3:38Speaker 1: It's clear that the liver is much more than just
- 3:41Speaker 1: a storage unit for energy. Its fine tune function can
- 3:44Speaker 1: be disrupted by a variety of factors, leading to a
- 3:48Speaker 1: cascade of issues, and it sounds like there are a
- 3:51Speaker 1: lot of things we can do to mitigate those risks,
- 3:54Speaker 1: especially around diet and exercise.
- 3:56Speaker 2: Absolutely, Rachel. Simple steps like reducing sugar, sweat and drinks,
- 4:00Speaker 2: improving muscle mass through resistance training, and being mindful of
- 4:04Speaker 2: alcohol consumption can go a long way in maintaining liver health.
- 4:08Speaker 2: It's all about balance and being proactive.
- 4:11Speaker 1: Well, thank you for walking me through all that. It's
- 4:14Speaker 1: quite reassuring knowing that there are actionable steps we can
- 4:17Speaker 1: take to protect this vital.
- 4:19Speaker 2: Organ anytime, Rachel, And remember staying informed and making small,
- 4:24Speaker 2: consistent changes can make a big difference in the long run.
- 4:27Speaker 2: Let's keep our listeners educated so they can make those
- 4:30Speaker 2: changes too.
- 4:31Speaker 1: So moving on from the basics, let's delve into the
- 4:34Speaker 1: stages of metabolic liver disease. As you mentioned, the liver
- 4:39Speaker 1: is pretty amazing at regulating glucose levels, but when metabolic
- 4:43Speaker 1: dysfunction sets in, it can lead to some serious issues.
- 4:47Speaker 1: Can you start by explaining how the initial metabolic stress
- 4:51Speaker 1: progresses to stidosis and then to statohepotitis.
- 4:55Speaker 2: Absolutely, Initially you have metabolic stress where the body struggle
- 5:00Speaker 2: to handle the excess energy coming in mainly from dietary
- 5:03Speaker 2: sources and an inactive lifestyle. This leads to an imbalance
- 5:07Speaker 2: where the body starts converting excess calories into triglycerides through
- 5:11Speaker 2: a process called denovo lipogenesis. These triglycerides get transported into
- 5:16Speaker 2: the liver by very low density lipoproteins veldlzls and are
- 5:21Speaker 2: stored as fat, leading to statosis. As the fat builds up,
- 5:26Speaker 2: the liver starts to lose its ability to efficiently process
- 5:29Speaker 2: and utilize the stored fats. When the liver fat levels
- 5:33Speaker 2: are high, it can trigger an inflammatory response, especially if
- 5:37Speaker 2: there are other metabolic risk factors at play. This inflammation
- 5:41Speaker 2: is the tipping point pushing metabolism from a state of
- 5:44Speaker 2: stress to statohepatitis. During this stage, liver cells start to
- 5:48Speaker 2: die and this signals the immune system to come in
- 5:51Speaker 2: and start the process of inflammation.
- 5:53Speaker 1: That transition from stytosis to statohepatitis really highlights the progression
- 5:58Speaker 1: from a storage issue to a full blown disease. Is
- 6:01Speaker 1: there any way to catch this early before it causes
- 6:04Speaker 1: significant damage to the liver.
- 6:06Speaker 2: That's a great question. Early detection is key. Even though
- 6:11Speaker 2: metabolic stress is hard to spot directly, we can use
- 6:14Speaker 2: biomarkers like liver enzyme levels to indicate subtle changes. However,
- 6:18Speaker 2: more specifically, the switch from simple stytosis to stytohepatitis where
- 6:23Speaker 2: inflammation kicks in, correlates with fibrosis development. Early fibrosis is reversible,
- 6:29Speaker 2: but once the liver starts forming scar tissue, it becomes permanent.
- 6:34Speaker 2: So the ideal scenario is to catch it before fibrosis
- 6:38Speaker 2: sets in.
- 6:38Speaker 1: Speaking of early detection, what are some risk factors that
- 6:42Speaker 1: might tip us off that we could be on that
- 6:44Speaker 1: path towards metabolic liver disease.
- 6:47Speaker 2: Several factors can indicate early metabolic dysfunction. One of the
- 6:52Speaker 2: main ones is visceral fat, which is more dangerous than
- 6:55Speaker 2: subcutaneous fat because it's actively releasing fatty acids directly into
- 6:59Speaker 2: the portal vein, affecting liver function. CT scans can estimate
- 7:04Speaker 2: visceral fat and independently predictstytosis even without considering body mass
- 7:09Speaker 2: index BMI or liver enzyme levels. Viscral fat levels greater
- 7:14Speaker 2: than two hundred square centimeters increase the risk of liver
- 7:18Speaker 2: stytosis seven and a half times compared to levels below
- 7:21Speaker 2: one hundred square centimeters. Another risk factor is muscle mass.
- 7:26Speaker 2: Skeletal muscle is a significant glucose sinc storing about seventy
- 7:30Speaker 2: five percent of the total body glucose capacity. Reduced muscle
- 7:34Speaker 2: mass can lead to a higher burden on the liver
- 7:36Speaker 2: for glucose management, contributing to metabolic liver disease. People with
- 7:41Speaker 2: sarcopenic obesity or skinny fat are particularly at risk even
- 7:46Speaker 2: if their BMI is normal.
- 7:48Speaker 1: That brings up an interesting point. Just having normal BMI
- 7:52Speaker 1: doesn't necessarily mean someone is safe from metabolic liver disease.
- 7:57Speaker 1: Can you give an example of a study that illustrates this.
- 8:00Speaker 2: Sure A study published in the Journal of Hepatology looked
- 8:03Speaker 2: at long term outcomes in individuals with metabolic abnormalities and
- 8:07Speaker 2: found that those with sarcopenic obesity had a four times
- 8:10Speaker 2: higher resolution rate of misslelled metabolic abnormality over five years
- 8:14Speaker 2: compared to those with minimal muscle gain. Resistance training can
- 8:18Speaker 2: be really effective in addressing and reversing metabolic dysfunction by
- 8:22Speaker 2: improving insulin sensitivity, which can reduce liver fat accumulation.
- 8:27Speaker 1: So lifestyle factors like training and diet play a huge
- 8:31Speaker 1: role here. What about dietary components specifically, you mentioned fructose
- 8:36Speaker 1: and sugar sweetened beverages. Can you elaborate on that, Yes, definitely.
- 8:42Speaker 2: When you look at the impact of fructose and sucrose
- 8:44Speaker 2: compared to glucose, fructose specifically affects denovo lipogenesis, doubling the
- 8:50Speaker 2: liver's fat making machinery. This doesn't mean fructose is particularly
- 8:55Speaker 2: harmful on its own, but it works synergistically with the
- 8:58Speaker 2: total caloric intel to increase liver fat accumulation. However, the
- 9:03Speaker 2: real key is the caloric excess. Excess calories, not the
- 9:08Speaker 2: type of sugar, are the primary driver of liver fat.
- 9:11Speaker 2: Sugar sweetened beverages, despite their high calorie density, are a
- 9:16Speaker 2: significant risk factor for non alcoholic fatty liver disease NAFFLED
- 9:21Speaker 2: because they are consumed without reducing other caloric intake, they
- 9:25Speaker 2: contribute to weight gain and metabolic dysfunction, pushing the liver
- 9:29Speaker 2: towards statosis.
- 9:31Speaker 1: Given all this, what about alcohol? How does alcohol factor
- 9:35Speaker 1: into metabolic liver disease and can it be considered a
- 9:38Speaker 1: separate risk factor.
- 9:40Speaker 2: Alcohol is a significant risk factor on its own and
- 9:43Speaker 2: can exacerbate metabolic liver disease. In fact, its harmful effects
- 9:48Speaker 2: on the liver are quite different from the impact of
- 9:51Speaker 2: caloric excess. Acetaldehyde, a byproduct of alcohol metabolism, is a
- 9:56Speaker 2: powerful driver of liver damage. Alcohol intake combined with stetosis
- 10:01Speaker 2: significantly ups the risk of all cause mortality, with that
- 10:05Speaker 2: risk increasing by forty percent, cancer mortality by one thirty
- 10:09Speaker 2: five percent, and liver specific mortality by over one thousand,
- 10:13Speaker 2: four hundred percent. Interestingly, the type of beverage and the
- 10:16Speaker 2: pattern of alcohol consumption can be more important than the
- 10:19Speaker 2: total amount. Seven drinks in one evening might be more
- 10:23Speaker 2: harmful than one drink per night. Phereas no direct human
- 10:26Speaker 2: data comparing binge drinking to daily drinking to support this
- 10:30Speaker 2: in the context of metabolic liver disease.
- 10:32Speaker 1: Yet that's a stark reminder of the importance of moderation
- 10:35Speaker 1: and lifestyle choices. Let's wrap up this section by touching
- 10:39Speaker 1: on genetic factors. You mentioned the PNPLA three gene, which
- 10:43Speaker 1: seems to play a significant role in metabolic liver disease development.
- 10:47Speaker 2: Exactly, the PNPA three gene variant is known to increase
- 10:51Speaker 2: the risk of liver fat accumulation, fibrosis, and overall metabolic
- 10:55Speaker 2: liver disease. People with two copies of this variant have
- 10:59Speaker 2: about double vs risk of developing liver fat compared to
- 11:02Speaker 2: those with just one or none. However, it's important to
- 11:05Speaker 2: note that genetics are just one piece of the puzzle.
- 11:08Speaker 2: Lifestyle environment and other factors also play significant roles. The
- 11:14Speaker 2: HSD seventeen B thirteen gene has a protective effect. Individuals
- 11:19Speaker 2: with certain loss of function variants in this gene tend
- 11:22Speaker 2: to have lower liver enzyme levels and reduced fibrosis risk,
- 11:26Speaker 2: which can partially offset the PNPLA three related risks. Finally,
- 11:32Speaker 2: ancestry matters. For example, people of Hispanic descent often have
- 11:37Speaker 2: higher sensitivity and susceptibility to missold and mash, while those
- 11:41Speaker 2: of African descent tend to develop metabolic risk at lower BMIs.
- 11:45Speaker 2: Asian ancestry is also linked to higher visceral fat and
- 11:50Speaker 2: lower subcutaneous fat. Accumulation, making them more prone to metabolic diseases.
- 11:56Speaker 1: Thanks for sharing all these complex, yet crucial details. It
- 12:00Speaker 1: really underscores the importance of both genetic and lifestyle factors
- 12:05Speaker 1: in managing and preventing metabolic liver disease.
- 12:08Speaker 2: Absolutely. The key takeaway is that while these risk factors
- 12:12Speaker 2: can increase the likelihood of developing metabolic liver disease, they
- 12:16Speaker 2: don't determine the outcome. Early detection, regular screening, and making
- 12:21Speaker 2: proactive lifestyle changes can significantly mitigate the risks. Speaker one.
- 12:26Speaker 2: So let's dive into the nitty gritty of metabolic liver disease.
- 12:31Speaker 2: We have talked a bit about the stages, but can
- 12:33Speaker 2: you articulate what happens on a molecular level when the
- 12:36Speaker 2: liver starts to get into trouble Speaker too. Absolutely. The
- 12:41Speaker 2: process usually begins with metabolic stress, where the liver has
- 12:44Speaker 2: to deal with an excess of calories, particularly from fructose
- 12:48Speaker 2: and sugar. As the liver tries to process this excess energy,
- 12:52Speaker 2: it starts to produce triglycerides through a process called denovolypogenesis.
- 12:58Speaker 2: These triglycerides are then packed into lipoproteins VLDLs and ldl's
- 13:04Speaker 2: end shipped off to adipose tissue. Now, while this process
- 13:09Speaker 2: is beneficial in small doses, it can really screw up
- 13:12Speaker 2: when it goes on consistently. Speaker one, Right, and this
- 13:16Speaker 2: is where we start to see the liver's response devolve.
- 13:19Speaker 2: As the adipose tissue gets more and more packed, it
- 13:22Speaker 2: loses its sensitivity to insulin, leading to insulin resistance. What
- 13:28Speaker 2: else does this insulin resistance do Speaker two. Well, Remember,
- 13:33Speaker 2: insulin typically tells the liver to stop making and releasing
- 13:36Speaker 2: glucose and to slow down fat production, but in this context,
- 13:40Speaker 2: the liver is stubborn and continues producing both. This high
- 13:44Speaker 2: insulin environment drives more fat synthesis in the liver, creating
- 13:48Speaker 2: a vicious cycle of increased fat and glucose. It's like
- 13:52Speaker 2: the liver is being instructed to stop burning, but instead
- 13:56Speaker 2: it just keeps piling on the fuel. Speaker one. That's
- 14:00Speaker 2: a really interesting point on the insulin resistance. Let's move
- 14:04Speaker 2: on to the next stage. Then. What happens when the
- 14:06Speaker 2: liver's response starts to fail Speaker two. Statosis sets in
- 14:11Speaker 2: when excess triglycerides start to accumulate in the hepatocytes. The
- 14:15Speaker 2: liver cells themselves. These fat droplets can press on the cells,
- 14:19Speaker 2: pushing them apart and disrupting the normal cell function. At
- 14:23Speaker 2: this stage, we can start to see changes in how
- 14:26Speaker 2: the liver metabolizes fats and glucose, making it harder for
- 14:30Speaker 2: the liver to clear itself of the accumulated fat Speaker one.
- 14:34Speaker 2: And as we mentioned, the liver isn't alone in this struggle, right,
- 14:37Speaker 2: what else is happening in the body that contributes to
- 14:40Speaker 2: this process? Speaker to Absolutely, the liver is part of
- 14:44Speaker 2: a larger network. The adipose tissue also becomes insulin resistant,
- 14:50Speaker 2: but this time it's because it can't clear the fatty
- 14:52Speaker 2: acids as efficiently as it once did, So fatty acids
- 14:56Speaker 2: start spilling into the bloodstream and the liver is four
- 15:00Speaker 2: to deal with them. Meanwhile, the diet itself contributes to
- 15:03Speaker 2: the problem by providing additional fats and sugars. The liver
- 15:07Speaker 2: is constantly under pressure, and as a result, it starts
- 15:11Speaker 2: to become insulin resistant itself, leading to the condition known
- 15:15Speaker 2: as selective hepatic insulin resistance Speaker one. So the liver
- 15:21Speaker 2: is stuck in this feedback loop, producing more fat and
- 15:24Speaker 2: releasing more glucose when it shouldn't. That sounds really bad,
- 15:29Speaker 2: and than to rease something called steatosis, which you mentioned earlier.
- 15:33Speaker 2: Why is this a warning sign? Speaker to statosis is
- 15:37Speaker 2: essentially the liver saying, hey, we have got a lot
- 15:40Speaker 2: of fat here. We might need to reassess our energy expenditure.
- 15:44Speaker 2: It's a warning sign of metabolic dysfunction. However, at this
- 15:48Speaker 2: early stage, the liver is still functioning reasonably well and
- 15:51Speaker 2: the fat isn't causing much damage. It's a bit like
- 15:54Speaker 2: packing on extra fuel for a long trip. If the
- 15:57Speaker 2: trip is short lived, no problem, but if the trip
- 16:01Speaker 2: is ongoing, issues will arise. Speaker one, got it. So
- 16:06Speaker 2: what happens when this early warning signal goes unchecked? Do
- 16:10Speaker 2: we see the development of steudohepatitis? Speaker two. Yes. If
- 16:15Speaker 2: the fatty build up continues, it triggers inflammation, leading to statohepatitis.
- 16:21Speaker 2: The accumulation of fat activates macrophages, immune cells that release
- 16:26Speaker 2: inflammatory signals. This influx of inflammation starts to disrupt the
- 16:30Speaker 2: liver's normal functions, leading to cell death and the release
- 16:34Speaker 2: of more fat and inflammation. It's like the liver is
- 16:37Speaker 2: starting to self destruct. Over time, this inflammation can spread,
- 16:42Speaker 2: leading to a cycle of cell death and fibrosis Speaker one.
- 16:46Speaker 2: And that's when things get really serious. What's the difference
- 16:49Speaker 2: between statosis and statohepatitis in terms of treatment and reversal?
- 16:55Speaker 2: Speaker two. Statosis is generally considered reversible if you can
- 16:59Speaker 2: break the sun tichel and reduce the dietary intake of
- 17:02Speaker 2: sugars and fats. Weight loss, exercise and dietary changes can
- 17:07Speaker 2: help reduce the fat content of the liver. However, once
- 17:11Speaker 2: inflammation and cell death start to occur, that's when things
- 17:15Speaker 2: get more challenging. While the liver can still potentially recover
- 17:19Speaker 2: from this, the damage is more significant and the fibrosis
- 17:23Speaker 2: that develops can be harder to reverse. Fibrosis marks the
- 17:26Speaker 2: transition from the reversible stages to the irreversible, where the
- 17:30Speaker 2: scar tissue formation is much more advanced. Speaker one. That
- 17:35Speaker 2: sounds dire. Let's talk about the real damage then. What
- 17:40Speaker 2: exactly does liver fibrosis mean for the functionality of the liver?
- 17:44Speaker 2: Speaker I. Liver fibrosis means that the liver is starting
- 17:49Speaker 2: to lose its normal structure. Scar tissue begins to replace
- 17:53Speaker 2: healthy liver tissue, and over time this can lead to cerhosis.
- 17:57Speaker 2: In cerhosis, the liver is full of scar tissue and
- 18:01Speaker 2: can no longer function properly. It's like the highway system
- 18:04Speaker 2: of the liver, once sleek and efficient, is now clogged
- 18:07Speaker 2: and inefficient. This can lead to all sorts of complications,
- 18:12Speaker 2: including portal hypertension, liver failure, and even liver cancer Speaker one.
- 18:17Speaker 2: And what about the risk of cancer in the advanced stages?
- 18:20Speaker 2: How does fibrosis relate to increased cancer risk? Speaker two.
- 18:25Speaker 2: Liver fibrosis creates an environment ripe for cancer development. The
- 18:30Speaker 2: scarring and inflammation can lead to genetic mutations and other
- 18:34Speaker 2: changes that promote the growth of cancer cells. In advanced stages,
- 18:38Speaker 2: the liver is less able to clear out these harmful
- 18:41Speaker 2: changes and it becomes a fertile ground for tumors. That's
- 18:45Speaker 2: why fibrosis is a critical predictor of poor outcomes in
- 18:49Speaker 2: metabolic liver disease. Speaker one. That's a sobering reality. Let's
- 18:54Speaker 2: shift to some of the key risk factors and modifiable behaviors.
- 18:58Speaker 2: Can you elaborate on the role of visceral fat, particularly
- 19:01Speaker 2: for liver health Speaker two. Visral fat is incredibly pernicious
- 19:06Speaker 2: for the liver. Unlike subcutaneous fat, which sits just under
- 19:10Speaker 2: the skin, visceral fat is nestled around the organs, including
- 19:13Speaker 2: the liver. It releases fatty acids, which are directly deposited
- 19:18Speaker 2: into the portal vein, the main vein that supplies the
- 19:21Speaker 2: liver with blood. This means the liver gets a double
- 19:23Speaker 2: hit of fatty acids which it has to process. The
- 19:26Speaker 2: more visceral fat you have, the more strain you put
- 19:30Speaker 2: on the liver. That's why we often see that visceral
- 19:32Speaker 2: fat greater than two hundred square centimeters increases the risk
- 19:36Speaker 2: of liver stitosis by seven point five times compared to
- 19:40Speaker 2: lower levels. Speaker one. What about specific diet factors? Are
- 19:45Speaker 2: there certain foods or beverages that are more problematic? Speaker two. Sure,
- 19:50Speaker 2: sugar sweetened beverages can be particularly harmful in studies. Fructose
- 19:55Speaker 2: and sucrose often found in these beverages seem to trigger
- 19:59Speaker 2: the liver's lipid making machinery much more than glucose. Sugar
- 20:03Speaker 2: sweetened beverages are calorie dense and easy to drink, so
- 20:07Speaker 2: they can contribute to excess calories driving liver fat accumulation.
- 20:12Speaker 2: For people with insulin resistance or liver disease, cutting back
- 20:16Speaker 2: on these is crucial Speaker one. And alcohol, of course,
- 20:20Speaker 2: is another big factor. How does alcohol interact with liver
- 20:24Speaker 2: health and what's the difference between occasional and chronic alcohol
- 20:27Speaker 2: consumption Speaker two. Alcohol is another major player. It can
- 20:32Speaker 2: cause fatty liver disease independently and can exacerbate the effects
- 20:37Speaker 2: of metabolic dysfunction. The primary harmful metabolite is acetaldehyde, which
- 20:42Speaker 2: can accumulate more quickly when alcohol is consumed rapidly. Seven
- 20:46Speaker 2: drinks in one evening might be more harmful than one
- 20:49Speaker 2: drink per night, even if the total daily consumption is
- 20:53Speaker 2: the same, because alcohol's impact can be more concentrated. Binge
- 20:57Speaker 2: drinking especially, can do a lot of damage. In terms
- 21:00Speaker 2: of genetics, the pnply three gene variant is more common
- 21:04Speaker 2: in some ethnic groups and increases the risk of liver
- 21:07Speaker 2: fat accumulation and fibrosis. Speaker one. And how does all
- 21:12Speaker 2: of this interplay with genetics and lifestyle factors? It seems
- 21:15Speaker 2: like terres a complex picture Speaker two. Exactly, Genetics, lifestyle,
- 21:21Speaker 2: and even gender can all play a role. For instance,
- 21:24Speaker 2: the pn play three variant is more common in people
- 21:27Speaker 2: with Hispanic ancestry, increasing their risk of mascled and MASH,
- 21:31Speaker 2: but it's not deterministic. Asian ancestry, on the other hand,
- 21:35Speaker 2: often develops metabolic risk at lower BMIs due to higher
- 21:39Speaker 2: visceral fat, and premenopausal women tend to have more protection
- 21:43Speaker 2: due to estrogen's effects on liver and fat health. It's
- 21:47Speaker 2: a complex web, and understanding in individual's unique risks involves
- 21:51Speaker 2: considering all of these factors. Speaker one, that's a lot
- 21:55Speaker 2: to take in, so in summary, the goal is to
- 21:58Speaker 2: prevent or mitigate me metabolic liver disease by managing dietary factors,
- 22:03Speaker 2: physical activity, and weight, all while being mindful of genetics
- 22:07Speaker 2: and risk factors. Any final thoughts or takeaways you de
- 22:11Speaker 2: like to leave us with Speaker too. Absolutely, the key
- 22:15Speaker 2: takeaway is that the liver is highly sensitive to the
- 22:18Speaker 2: lifestyle we lead. By making some simple but meaningful changes,
- 22:23Speaker 2: we can prevent or at least delay the progression of
- 22:27Speaker 2: metabolic liver disease. Regular exercise, reducing sugar and alcohol intake,
- 22:33Speaker 2: and being mindful of our diet can all make a
- 22:35Speaker 2: big difference. And for those already at risk, understanding the
- 22:39Speaker 2: specific factors that put them at higher risk can guide
- 22:42Speaker 2: targeted interventions. It's all about staying informed and taking proactive steps.
- 22:47Speaker 1: So we have talked a lot about metabolic liver disease
- 22:50Speaker 1: and its progression, but let's get into some specific behaviors
- 22:54Speaker 1: and environmental factors that can either help or harm. First off,
- 22:59Speaker 1: it's it's clear that excess calories are a primary driver.
- 23:03Speaker 1: How exactly does this process kick off in the liver?
- 23:06Speaker 2: Absolutely, when we have a calorie surplus, the extra energy
- 23:10Speaker 2: gets stored as triglycerides in the liver through a process
- 23:14Speaker 2: called denovo lipigenesis. This isn't inherently bad, but when it
- 23:18Speaker 2: happens chronically, it leads to a build up of fat,
- 23:21Speaker 2: which is the hallmark of metabolic dysfunction. This fat then
- 23:25Speaker 2: gets packaged into APO containing particles like VLDLs and LDLs,
- 23:30Speaker 2: which are sent to the adipose tissue for storage. However,
- 23:34Speaker 2: as the adipose tissue gets fuller, it loses its responsiveness
- 23:38Speaker 2: to insulin, leading to insulin resistance. This insulin resistance causes
- 23:43Speaker 2: fatty acids to be released into the bloodstream, and the
- 23:46Speaker 2: liver has to process these fatty acids, leading to more
- 23:50Speaker 2: fat production and a vicious cycle that perpetuates the problem.
- 23:54Speaker 1: And this is where the liver starts to see stress. Right,
- 23:57Speaker 1: Can you walk us through how that initial metabolic stress
- 24:00Speaker 1: turns into a condition like non alcoholic fatty liver disease nafhlold.
- 24:05Speaker 2: Certainly, the initial metabolic stress leads to stytosis or fat
- 24:10Speaker 2: accumulation in the liver. Historically, this was simply called nafool D. However,
- 24:16Speaker 2: with the progression of the disease, it can become non
- 24:19Speaker 2: alcoholic sttohepatitis. NASH is characterized by inflammation and liver cell damage.
- 24:26Speaker 2: This is when the liver fat triggers inflammatory responses from
- 24:29Speaker 2: immune cells, leading to a wave of cell death and
- 24:32Speaker 2: the formation of scar tissue or fibrosis. So the transition
- 24:37Speaker 2: from NAFFOLD to NASH and then to fibrosis is essentially
- 24:41Speaker 2: the liver trying to heal itself but failing due to
- 24:44Speaker 2: constant metabolic stress.
- 24:45Speaker 1: That sounds quite dire. But is this all irreversible or
- 24:50Speaker 1: can early stages be reversed?
- 24:52Speaker 2: Great question. The good news is that the first three
- 24:55Speaker 2: stages initial metabolic stress, statosis, and statohepatitis are reversible. The
- 25:01Speaker 2: problem arises when fibrosis sets in. While it can be
- 25:04Speaker 2: stopped and even reversed if caught early, the structural changes
- 25:08Speaker 2: in the liver at this stage make it significantly harder
- 25:10Speaker 2: to address early intervention. Lifestyle changes and potentially medical interventions
- 25:16Speaker 2: can help prevent progression to fibrosis, but once fibrosis is established,
- 25:21Speaker 2: the liver's architecture is disrupted, making it nearly irreversible.
- 25:25Speaker 1: And what about other factors? We mentioned alcohol? But what
- 25:29Speaker 1: about sugar sweetened beverages? How do they fit into this picture?
- 25:34Speaker 2: Sugar sweetened beverages, or SSBs are a significant concern. Studies
- 25:39Speaker 2: have shown that fructose found in high levels in SSBs
- 25:43Speaker 2: can specifically target the liver's machinery for making fat, even
- 25:47Speaker 2: more so than glucose. This means that while caloric excess
- 25:50Speaker 2: is a primary driver, the type of calories can matter
- 25:53Speaker 2: a lot. SSBs are particularly concerning due to their high
- 25:57Speaker 2: calorie density and easy consumption. For individuals with insulin resistance
- 26:03Speaker 2: or existing liver disease, cutting back on these beverages can
- 26:06Speaker 2: be beneficial, right The key.
- 26:08Speaker 1: Here seems to be managing calories in their types especially
- 26:12Speaker 1: in light of other risk factors like genetics. Let's talk
- 26:16Speaker 1: about that for a bit. There are specific genetic variants
- 26:21Speaker 1: that can influence risk, like pn el E three correct.
- 26:25Speaker 2: Yes, exactly, the PNPLA three gene variant is a key
- 26:29Speaker 2: player here. Individuals with two copies of this variant have
- 26:33Speaker 2: a much higher risk of accumulating liver fat and developing
- 26:36Speaker 2: inflammation and fibrosis, even if they have normal metabolic risk
- 26:40Speaker 2: factors like BMI and liver enzymes. On the other hand,
- 26:44Speaker 2: there are protective genetic variants like loss of function variants
- 26:48Speaker 2: in the HSD seventeen B thirteen gene, which can reduce
- 26:52Speaker 2: the risk of fibrosis.
- 26:53Speaker 1: And this genetic risk isn't deterministic, right. How important are
- 26:58Speaker 1: lifestyle factors in this context?
- 27:00Speaker 2: Absolutely, Lifestyle factors play a crucial role. While genetic risk
- 27:05Speaker 2: is important, it's not set in stone. For example, muscle
- 27:10Speaker 2: mass is a significant sink for glucose, storing about three
- 27:14Speaker 2: quarters of the body's total glucose capacity. Reduced muscle mass
- 27:18Speaker 2: shifts the burden of glucose management to the liver, contributing
- 27:22Speaker 2: to metabolic dysfunction. Skeletal muscle loss or skinny fat is
- 27:27Speaker 2: linked to metabolic dysfunction even in individuals with a normal BMI.
- 27:32Speaker 2: Studies show that gaining muscle mass can significantly improve metabolic outcomes,
- 27:37Speaker 2: underscoring the importance of resistance training and lifestyle interventions.
- 27:41Speaker 1: That's a powerful point. Let's not forget about alcohol either.
- 27:46Speaker 1: Can you talk a bit about its role in this context?
- 27:49Speaker 2: Absolutely? Alcohol consumption is another major risk factor, and it
- 27:53Speaker 2: works independently of caloric excess. Alcohol can cause fatty liver independently,
- 27:59Speaker 2: and its effects are more common than previously acknowledged, often
- 28:03Speaker 2: requiring liver transplants. The alcohol's primary harmful component is acetaldehyde,
- 28:09Speaker 2: which accumulates faster when alcohol consumption exceeds one drink per hour.
- 28:14Speaker 2: This can happen even with a daily drinking pattern, but
- 28:18Speaker 2: binge drinking over a short period can be even more harmful.
- 28:21Speaker 2: Alcohol and metabolic liver disease have a synergistic effect, and
- 28:25Speaker 2: the combination can significantly increase the risk of liver related mortality.
- 28:30Speaker 1: All of this underscores the complexity of liver health. What
- 28:35Speaker 1: should individuals do based on this information?
- 28:38Speaker 2: The takeaways are clear. First, managing caloric intake and reducing
- 28:42Speaker 2: sugar sweetened beverages can help. Second, maintaining a healthy weight
- 28:47Speaker 2: and muscle mass is crucial. Third, limiting alcohol consumption is advised,
- 28:53Speaker 2: especially if there are other risk factors at play. Regular
- 28:56Speaker 2: blood work to monitor liver enzymes is important, but it's
- 29:00Speaker 2: just one part of the picture. Genetic, environmental, and lifestyle
- 29:05Speaker 2: factors all need to be considered for a comprehensive approach
- 29:08Speaker 2: to liver health.
- 29:09Speaker 1: So to summarize where we are, metabolic dysfunction is a
- 29:13Speaker 1: progressive condition that can lead to liver disease. Let's break
- 29:17Speaker 1: it down. The early stages involve metabolic stress and stytosis,
- 29:22Speaker 1: which are largely reversible with lifestyle changes. But as the
- 29:26Speaker 1: disease progresses, we see inflammation and the eventual onset of fibrosis,
- 29:31Speaker 1: which is harder to fully reverse. Can you explain how
- 29:35Speaker 1: selective hepatic insulin resistance plays a role in this progression?
- 29:39Speaker 2: Absolutely, Selective hepatic insulin resistance is a key player. Normally,
- 29:45Speaker 2: insulin suppresses hipadic glucose production and promotes fat export from
- 29:49Speaker 2: the liver. However, when hepatic cells become selectively resistant to insulin,
- 29:55Speaker 2: they continue to produce glucose and also fail to export
- 29:58Speaker 2: scored fats. This creates. It's a vicious cycle. High glucose
- 30:02Speaker 2: levels stimulate more insulin release, which in turn exacerbates the
- 30:06Speaker 2: hepatic insulin resistance. This leads to a net increase in
- 30:10Speaker 2: glucose and fat release from the liver into the bloodstream,
- 30:13Speaker 2: contributing to overall metabolic dysfunction.
- 30:16Speaker 1: That's a really important point. And the consequence of this
- 30:19Speaker 1: constant release of liver produced glucose and lipids into the bloodstream.
- 30:24Speaker 2: Well, it means that the liver is perpetuating the metabolic
- 30:27Speaker 2: imbalance constantly. High glucose levels promote further insulin resistance in
- 30:32Speaker 2: both liver and adipose tissue, while the increased lipids can
- 30:36Speaker 2: lead to liver cell death and inflammation. This inflammation further
- 30:40Speaker 2: disrupts insulin signaling, creating a cascade effect that makes the
- 30:44Speaker 2: condition progressively worse. In essence, the liver is becoming a
- 30:48Speaker 2: player in the metabolic dysfunction rather than just a spectator.
- 30:52Speaker 1: Right, and this is why we see things like insulin
- 30:55Speaker 1: resistance in the liver as a critical factor in the
- 30:58Speaker 1: progression to statohepotitis. Right, It's not just about the fat
- 31:02Speaker 1: and the liver, but the ongoing inflammatory response and the
- 31:06Speaker 1: inability to effectively regulate glucose and lipids exactly.
- 31:10Speaker 2: Insulin resistance in the liver is a defining characteristic of NASH.
- 31:15Speaker 2: It's the liver's failure to respond to insulin properly that
- 31:18Speaker 2: drives the inflammatory response and ultimately the progression to fibrosis.
- 31:23Speaker 2: This is why addressing insulin resistance through lifestyle changes is
- 31:27Speaker 2: crucial in preventing and treating this condition.
- 31:30Speaker 1: So, moving on to the next stages, what happens when
- 31:34Speaker 1: we get to staudohepatitis and then fibrosis and is there
- 31:39Speaker 1: any point of no return in this process?
- 31:42Speaker 2: In the transition from statosis to statohepatitis, you have that
- 31:46Speaker 2: initial metabolic stress turning into inflammation. As liver cells die,
- 31:51Speaker 2: immune cells are recruited to the site, causing a release
- 31:54Speaker 2: of inflammatory mediators. This creates a feedback loop where inflammatory
- 31:59Speaker 2: signals further impair insulin signaling, making the liver less able
- 32:03Speaker 2: to regulate glucose and fat. Over time, this chronic inflammation
- 32:08Speaker 2: leads to scarring or fibrosis as the liver tries to
- 32:12Speaker 2: repair itself. The progression from stetosis to fibrosis is largely irreversible,
- 32:18Speaker 2: which is why early intervention is so important and when.
- 32:21Speaker 1: We get to fibrosis, trees really know going back? Is
- 32:25Speaker 1: that right?
- 32:26Speaker 2: Essentially? Yes, Fibrosis is where the liver starts to form
- 32:30Speaker 2: permanent scar tissue. While it's not entirely impossible to reverse
- 32:35Speaker 2: the damage, it becomes much harder the longer the process continues.
- 32:39Speaker 2: The scarring disrupts the architecture of the liver and can
- 32:42Speaker 2: eventually lead to cirrhosis, where the liver can no longer
- 32:46Speaker 2: function properly. However, if caught early enough, fibrosis can be
- 32:51Speaker 2: managed and the liver may eventually regenerate. Although this depends
- 32:55Speaker 2: on the extent.
- 32:55Speaker 1: Of the damage, it's really clear that prevention or catching
- 32:59Speaker 1: this processor is crucial. And given the genetic and lifestyle
- 33:04Speaker 1: factors at play, what advice would you give to people
- 33:07Speaker 1: to protect their liver health.
- 33:09Speaker 2: Absolutely. First, regular exercise, especially resistance training, can help improve
- 33:15Speaker 2: insulin sensitivity and reduce overall fat, which lowers the risk
- 33:20Speaker 2: of metabolic dysfunction. Second, dietary changes such as reducing sugar
- 33:26Speaker 2: and alcohol intake can significantly impact liver health. Third, maintaining
- 33:31Speaker 2: a healthy weight and addressing insulin resistance through lifestyle changes
- 33:35Speaker 2: can go a long way. Lastly, genetic predispositions aside. People
- 33:40Speaker 2: should be vigilant about managing their overall metabolic health, especially
- 33:44Speaker 2: if they have risk factors like obesity or a family
- 33:47Speaker 2: history of liver disease.
- 33:49Speaker 1: And it's important for people to know that even small
- 33:51Speaker 1: changes can make a big difference. That's the message we
- 33:55Speaker 1: should be spreading. Early intervention and prevention are.
- 33:59Speaker 2: Key, absolutely, and tools like regular blood tests, especially for
- 34:03Speaker 2: liver enzymes, and imaging like CT scans to assess visceral
- 34:07Speaker 2: fat can help catch issues. Early regular checkups with a
- 34:11Speaker 2: healthcare provider familiar with metabolic liver disease can also be
- 34:15Speaker 2: incredibly beneficial.
- 34:16Speaker 1: Well, that's a great overview of the progression and prevention
- 34:19Speaker 1: of metabolic liver disease. Thank you for walking us through it,
- 34:23Speaker 1: my pleasure.
- 34:25Speaker 2: And thank you for your dedication to helping people understand
- 34:28Speaker 2: the complexities of liver health.
- 34:29Speaker 1: That brings us to the end of today's episode. Thank
- 34:32Speaker 1: you so much for spending part of your day with me.
- 34:35Speaker 1: If you found this episode's tips helpful and want to
- 34:38Speaker 1: make sure you don't miss the next conversation, please take
- 34:41Speaker 1: a quick second to hit that subscribe or follow button
- 34:44Speaker 1: on whatever platform you are listening on, it's a completely
- 34:47Speaker 1: free way to support the show and helps more people
- 34:50Speaker 1: find us. This podcast is independently produced, so if you
- 34:54Speaker 1: are ever in a position where you would like to
- 34:56Speaker 1: help keep it running, we do accept small donations and
- 35:00Speaker 1: find a link right in the episode description below to
- 35:03Speaker 1: buy us a coffee or contribute what you can. Every
- 35:06Speaker 1: bit genuinely helps take care of yourself, stay balanced, and
- 35:11Speaker 1: we will talk again soon.